[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2021,71(3):209-249.
[2] 沈中阳.中国肝移植的发展与创新［J］.临床肝胆病杂志,2019,35(11):2377-2385.
SHEN ZY.Development and innovation of liver transplantation in China［J］.Journal of Clinical Hepatobiliary Diseases,2019,35(11):2377-2385.
[3]RINKU DUTTA,RAM IM.Recent advances in hepatocellular carcinoma therapy［J］.Pharmacology & Therapeutics,2017,173:106-117.
[4] KALLRRI R.The biology and function of exosomes in cancer［J］.J Clin Invest,2016,126(4):1208-1215.
[5] TKACH M,THERY C.Communication by extracellular vesicles:where we are and where we need to go［J］.Cell,2016,164(6):1226-1232.
[6] GUO W,GAO Y,LI N,et al.Exosomes:New players in cancer (Review)［J］.Oncol Rep,2017,38(2):665-675.
[7] 邓雅言，黄玉娟，叶家享，等.外泌体传递的非编码RNA在鼻咽癌发生发展中的作用［J］.现代肿瘤医学,2022,30(15):2842-2846.
DENG YY，HUANG YJ，YE JX，et al.The role of exosome-delivered non-coding RNAs in the development and progression of nasopharyngeal carcinoma［J］.Modern Oncology,2022,30(15):2842-2846.
[8] WEN SW,LIMA LG,LOBB RJ,et al.Breast cancer-derived exosomes reflect the cell-of-origin phenotype［J］.Proteomics,2019,19(8):e1800180.
[9] ARISHE OO,LANE-CORDOVA A,WEBB RC.Placental exosomes trigger maternal inflammation and vascular dysfunction in preeclampsia［J］. J Biomed Res Environ Sci,2021,2(12):1211-1215.
[10] XIE JY,WEI JX,LV LH,et al.Angiopoietin-2 induces angiogenesis via exosomes in human hepatocellular carcinoma［J］.Cell Commun Signal,2020,18:46.
[11] XU H,DONG X,CHEN Y,et al.Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma［J］.Clin Chem Lab Med,2018,56:479-484.
[12] CHENG LF,WANG YH,HUANG L.Exosomes from M1-polarized macrophages potentiate the cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node［J］.Mol Ther,2017,25:1665-1675.
[13] NAJAFI M,HASHEMI GORADEL N,FARHOOD B,et al.Macrophage polarity in cancer:a review［J］.J Cell Biochem,2019,120(3):2756-2765.
[14] LU Z,ZUO B,JING R,et al.Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models［J］.J Hepatol,2017,67(4):739-748.
[15]WANG G,LIU W,ZOU Y,et al.Three isoforms of exosomal circPTGR1 promote hepatocellular carcinoma metastasis via the miR449a-MET pathway［J］.EBio Medicine,2019,40:432-445.
[16]ZHOU Y,REN H,DAI B,et al.Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts［J］.J Exp Clin Cancer Res,2018,37:324.
[17] YE L,ZHANG Q,CHENG Y,et al.Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion［J］.J Immunother Cancer,2018,6:145.
[18]FANG T,LV H,LV G,et al.Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer［J］.Nat Commun,2018,9:191.
[19]MATSUURA Y,WADA H,EGUCHI H,et al.Exosomal miR-155 derived from hepatocellular carcinoma cells under hypoxia promotes angiogenesis in endothelial cells［J］.Dig Dis Sci,2019,64:792-802.
[20] DONG SS,DONG DD,YANG ZF,et al.Exosomal miR-3682-3p suppresses angiogenesis by targeting ANGPT1 via the RAS-MEK1/2-ERK1/2 pathway in hepatocellular carcinoma［J］.Front Cell Dev Biol,2021,9:633358.
[21] LIN XJ,FANG JH,YANGG XJ,et al.Hepatocellular carcinoma cell-secreted exosomal MicroRNA-210 promotes angiogenesis in vitro and in vivo［J］.Mol Ther Nucleic Acids,2018,11:243-252.
[22]FU Q,ZHANG Q,LOU Y,et al.Primary tumor-derived exosomes facilitate metastasis by regulating adhesion of circulating tumor cells via SMAD3 in liver cancer［J］.Oncogene,2018,37:6105-6118.
[23] JIANG K,DONG C,YIN Z,et al.Exosome-derived ENO1 regulates integrin α6β4 expression and promotes hepatocellular carcinoma growth and metastasis［J］.Cell Death Dis,2020,11:972.
[24]FU X,LIU M,QU S,et al.Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway［J］.J Exp Clin Cancer Res,2018,37:52.
[25] LIU H,CHEN W,ZHI X,et al.Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility［J］.Oncogene,2018,37:4964-4978.
[26] WU J,GAO W,TANG Q,et al.M2 macrophage-derived exosomes facilitate HCC metastasis by transferring αM β2 integrin to tumor cells［J］.Hepatology,2021,73(4):1365-1380.
[27]WANG Y,WANG B,XIAO S,et al.miR-125a/b inhibits tumor-associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90［J］. J Cell Biochem,2018,120:3046-3055.
[28] LIU G,OUYANG X,SUN Y,et al.The miR-92a-2-5p in exosomes from macrophages increases liver cancer cells invasion via altering the AR/PHLPP/p-AKT/β-catenin signaling［J］.Cell Death Differ,2020,27(12):3258-3272.
[29]TIAN BZ,ZHOU L,WANG J,et al.miR-660-5p-loaded M2 macrophages-derived exosomes augment hepatocellular carcinoma development through regulating KLF3［J］.Int Immunopharmacol,2021,101(Pt B):108157.
[30] ZHANG H,DENG T,GE S,et al.Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7［J］.Oncogene,2019,38(15):2844-2859.
[31]ZHANG Z,LI X,SUN W,et al.Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis［J］.Cancer Lett,2017,397:33-42.
[32]XUE X,WANG X,ZHAO Y,et al. Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A［J］.Biochem Biophys Res Commun,2018,502:515-521.
[33]LI B,MAO R,LIU C,et al.LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells［J］.Life Sci,2018,197:122-129.
[34]TANG J,LI Y,LIU K,et al.Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma［J］.Minerva Med,2018,109:15-23.
[35]魏小军.肝癌血浆外泌体的蛋白质组学研究［D］.北京：军事科学院,2020.
WEI XJ.A proteomic investigation of plasma-derived exosomes in hepatocellular carcinoma［D］.Beijing:Military Science Academy,2020.
[36]TAYYABA,REHMAN FU,SHAIKH S,et al.In situ self-assembled Ag-Fe3O4 nanoclusters in exosomes for cancer diagnosis［J］.J Mater Chem B,2020,8(14):2845-2855.
[37] LIU X，CHENG D，CUI M,et al.Exosome marker proteins of tumor-sssociated fibroblasts and exosome-derived miR-92a-3p act as potential biomarkers for liver cancer［J］.Crit Rev Eukaryot Gene Expr,2022,32(1):49-57.
[38]纪文静,白洁,包永星.基于纳米材料提取肝细胞癌患者血浆外泌体的研究［J］.胃肠病学和肝病学杂志,2020,29(04):450-455.
JI WJ,BAI J,BAO YX.Extraction of plasma exosomes from patients with hepatocellular carcinoma based on nanomaterials［J］.Chin J Gastroenterol Hepatol,2020,29(04):450-455.
[39]WANG S,YANG Y,SUN L,et al.Exosomal microRNAs as liquid biopsy biomarkers in hepatocellular carcinoma［J］.Onco Targets Ther,2020,13:2021-2030.
[40] 夏泽宇.肝癌患者血浆外泌体蛋白质组学与肝癌诊断标志物的研究［D］.桂林：桂林医学院,2021.
XIA ZY.Study on plasma exosome proteomics and diagnosticmarkers of Liver cancer in patients with Liver cancer［D］.Guilin:Guilin Medical University,2021.
[41] LYU L,YANG W,YAO J,et al.The diagnostic value of plasma exosomal hsa_circ_0070396 for hepatocellular carcinoma［J］.Biomarkers in Medicine,2021，15(5):1-10.
[42] 孟俊,王俊青,费晓春,等.血浆外泌体circRNA诊断HCC联合检测模型的建立与验证［J］.检验医学,2022,37(1):1-10.
MENG J,WANG JQ,FEI XC,et al.Establishment and validation of a plasma exosome-derived circular RNA model for HCC diagnosis［J］.Laboratory Medicine,2022,37(1):1-10.
[43] LIU W,HU J,ZHOU K,et al.Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma［J］.Onco Targets Ther,2017,10:3843-3851.
[44]CHO HJ,EUN JW,BAEK GO,et al.Serum exosomal microRNA,miR-10b-5p,as a potential diagnostic biomarker for early-stage hepatocellular carcinoma［J］. J Clin Med,2020,9(1):281.
[45] COBB DA，KIM OK，GILDEN-MASON L，et al.Hepatocyte-derived exosomes promote T follicular regulatory cell expansion during hepatitis C virus infection［J］.Hepatology,2018,67(1):71-85.
[46] WANG H,HOU L,LI A,et al.Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma［J］.Biomed Res Int,2014,2014:864-894.
[47] SHI J.Considering exosomal miR-21 as a biomarker for cancer［J］.J Clin Med,2016,5(4):42.
[48] PU C,HUANG H,WANG Z,et al.Extracellular vesicle-associated mir-21 and mir-144 are markedly elevated in serum of patients with hepatocellular carcinoma［J］.Front Physiol,2018,9:930.
[49]XUE X,ZHAO Y,WANG X,et al.Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma［J］.J Cell Biochem,2019,120:135-142.
[50]SUN L,SU Y,LIU X,et al.Serum and exosome long non coding RNAs as potential biomarkers for hepatocellular carcinoma［J］.J Cancer，2018，9:2631-2639.
[51]ZHANG C,YANG X,QI Q,et al.lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma［J］.Cancer Biomark,2018，1(3):651-659.
[52]XU H,CHEN Y,DONG X,et al.Serum exosomal long noncoding RNAs ENSG00000258332.1 and LINC00635 for the diagnosis and prognosis of hepatocellular carcinoma［J］.Cancer Epidemiol Biomark Prev，2018，27:710-716.
[53]WANG F，LI L，PIONTEK K，et al.Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma［J］.Hepatology,2018,67(3):940-954.
[54] MA D,GAO X,LIU Z,et al.Exosome-transferred long non-coding RNA ASMTL-AS1 contributes to malignant phenotypes in residual hepatocellular carcinoma after insufficient radiofrequency ablation［J］.Cell Prolif,2020,53:e12795.
[55] QIAO L,HU S,HUANG K,et al.Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs［J］.Theranostics,2020,10(8):3474-3487.
[56] RAO Q,ZUO B,LU Z,et al.Tumor - derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro［J］.Hepatology,2016,64(2):456-472.
[57]LIANG G,KAN S,ZHU Y,et al.Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells［J］.Int J Nanomedicine,2018,13:585-599.
[58]RIVOLTINI L,CHIODONI C,SQUARCINA P,et al.TNF-related apoptosis-inducing ligand (TRAIL)-armed exosomes deliver proapoptotic signals to tumor site［J］.Clin Cancer Res，2016，22：3499-3512.
[59]SHI S,RAO Q,ZHANG C,et al.Dendritic cells pulsed with exosomes in combination with PD-1 antibody increase the efficacy of sorafenib in hepatocellular carcinoma model［J］.Transl Oncol，2018，11:250 - 258.
[60] YANG B,FENG X,LIU H,et al.High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma［J］.Oncogene,2020,39(42):6529-6543.
[61] FU C,ZHOU L,MI QS,et al.DC-based vaccines for cancer immunotherapy［J］.Vaccines (Basel),2020,8(4):706.
[62] ZHONG X,ZHOU Y,CAO Y,et al.Enhanced antitumor efficacy through microwave ablation combined with a dendritic cell-derived exosome vaccine in hepatocellular carcinoma［J］. Int J Hyperthermia,2020,37(1):1210-1218.
[63] LI J,HUANG S,ZHOU Z,et al.Exosomes derived from rAAV/AFP-transfected dendritic cells elicit specific T cell-mediated immune responses against hepatocellular carcinoma［J］.Cancer Manag Res,2018,10:4945-4957.
[64] SUN Q,ZHANG X,TAN Z,et al.Bone marrow mesenchymal stem cells-secreted exosomal microRNA-205-5p exerts inhibitory effect on the progression of liver cancer through regulating CDKL3［J］.Pathol Res Pract,2021,225:153549.
[65] GU H,YAN C,WAN H,et al.Mesenchymal stem cell-derived exosomes block malignant behaviors of hepatocellular carcinoma stem cells through a lncRNA C5orf66-AS1/microRNA-127-3p/DUSP1/ERK axis［J］.Hum Cell,2021,34(6):1812-1829.
[66] LOU G,CHEN L,XIA C,et al.MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway［J］.J Exp Clin Cancer Res,2020,39(1):4.
[67]WANG LT,LIU KY,CHIOU SS,et al.Phosphorylation of intestine-specific homeobox by ERK1 modulates oncogenic activity and sorafenib resistance［J］.Cancer Lett,2021,520:160-171.
[68]LI H,YANG C,SHI Y,et al.Exosomes derived from siRNA against GRP78 modified bone-marrow-derived mesenchymal stem cells suppress sorafenib resistance in hepatocellular carcinoma［J］. J Nanobiotechnology,2018,16:103.
[69] MAQSOOD M,KANG M,WU X,et al.Adult mesenchymal stem cells and their exosomes:sources,characteristics,and application in regenerative medicine［J］.Life Sci,2020,256:118002.
[70]LIANG L,ZHAO L,WANG Y.Treatment for hepatocellular carcinoma is enhanced when norcantharidin is encapsulated in exosomes derived from bone marrow mesenchymal stem cells［J］.Mol Pharm,2021,18:1003-1013.
[71]LOU G,SONG X,YANG F,et al.Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma［J］.J Hematol Oncol,2015,8(1):122.
[72] KO SF,YIP HK,ZHEN YY,et al.Adipose-derived mesenchymal stem cell exosomes suppress hepatocellular carcinoma growth in a rat model:apparent diffusion coefficient,natural killer T-cell responses,and histopathological features［J］.Stem Cells Int,2015，2015:1-11.
[73] WARARAT C, PUKKAVADEE N,SURADEJ H,et al.Red blood cell extracellular vesicle-based drug delivery:challenges and opportunities［J］.Front Med (Lausanne),2021,8:761362.
[74]USMAN WM,PHAM TC,KWOK YY,et al.Efficient RNA drug delivery using red blood cell extracellular vesicles［J］.Nat Commun,2018,9:2359.
[75]ZHANG G,HUANG X,XIU H,et al.Extracellular vesicles:Natural liver accumulating drug delivery vehicles for the treatment of liver diseases［J］.J Extracell Vesicles,2020,10(2):e12030.
[76] LIU Y,TAN J,OU S,et al.Adipose-derived exosomes deliver miR-23a/b to regulate tumor growth in hepatocellular cancer by targeting the VHL/HIF axis［J］.J Physiol Biochem,2019,75(3):391-401.
[77] ZHOU Y,TANG W,ZHUO H,et al.Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/nuclear factor-kappa B (NF-κB) pathway［J］.Bioengineered,2022,13(3):4786-4797.
[78] SEMAAN L,ZENG Q,LU Y,et al.MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs［J］.Oncotarget,2021,12(3):185-198.
[79] DU J,WAN Z,WANG C,et al.Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy［J］.Theranostics,2021,11(17):8185-8196.
[80] ZHANG K,SHAO C,ZHU J,et al.Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma［J］.Biosci Rep,2020,40(7):BSR20194026.
[81]WANG F,LI L,PIONTEK K,et al.Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma［J］.Hepatology,2018,67:940-954.
[82] WANG G,ZHAO W,WANG H,et al.Exosomal miR-744 inhibits proliferation and sorafenib chemoresistance in hepatocellular carcinoma by targeting PAX2［J］.Med Sci Monit,2019,25:7209-7217.
[83] WANG J,PU J,ZHANG Y,et al.Exosome-transmitted long non-coding RNA SENP3-EIF4A1 suppresses the progression of hepatocellular carcinoma［J］.Aging (Albany NY),2020,12:11550-11567.
[84] ZHANG C,CHEN B,JIAO A,et al.miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma［J］.BMC Cancer,2018,18(1):1179.
[85] ZHANG Y,ZHANG D,JIANG J,et al.Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma［J］.Oncol Rep,2017,37(1):323-332.
[86]CHEN W,QUAN Y,FAN S,et al.Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression［J］.Cancer Lett,2020,475:119-128.
[87]WAHLGREN J, DEL KARLSON T, BRISSLERT M,et al.Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes［J］.Nucleic Acids Res,2012,40(17):e130.
[88] RADHA M,FARRUKH A,JEYAPRAKASH J,et al. Bovine milk-derived exosomes for drug delivery［J］.Cancer Lett,2016,371(1):48-61.
[89] MELNIK BC.Dairy consumption and hepatocellular carcinoma risk［J］.Ann Transl Med,2021,9(8):736.
[90] MELNIK BC,SCHMITZ G.Exosomes of pasteurized milk:potential pathogens of western diseases［J］.J Transl Med,2019,17(1):3.
[91] EL-KATTAWY AM,ALGEZAWY O,ALFAIFI MY,et al.Therapeutic potential of camel milk exosomes against HepaRG cells with potent apoptotic,anti-inflammatory,and anti-angiogenesis effects for colostrum exosomes［J］.Biomed Pharmacother,2021,143:112220.